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Group C streptococci (GCS) are livestock pathogens and they often cause zoonotic diseases in humans.They are Gram-positive, in
mostly 𝛽-hemolytic and facultative anaerobes. Because of their close evolutionary kinship with group A streptococci (GAS), GCS
share many common virulence factors with GAS and cause a similar range of diseases. Due to the exchange of genetic material
with GAS, GCS belong to bacteria that are difficult to be distinguished from group A streptococci; GCS are often treated in
microbiological diagnostics as contamination of the culture. This report focuses mainly on the pathogenicity of virulent species
of GCS and their association with human diseases. The condition that is most frequently quoted is pharyngitis. In this paper, the
virulence factors have also been mentioned and an interesting link has been made between GCS and the pathogenesis of rheumatic
diseases among the native people of India and Aboriginal populations.
1. Introduction
Group C streptococci, according to Lancefield’s work of
1933, belong to Gram-positive bacteria, catalase-negative and
facultative anaerobes [1–4]. The division of streptococci into
groups was made by Lancefield; the research concerned 106
strains of Streptococcus haemolyticus isolated from many
sources (humans, animals, and dairy products) andwas based
on the carbohydrate C expressed in the wall of bacteria
[4]. Using sera, agglutination reactions, and reactions of
precipitation Lancefield classified the strains into respective
groups [4]. Based on the results of the anti-C precipitin test,
it was stated that the strains of group C came from various
sources other than human and numbered 49 strains. Those
strains of group C can hardly, or impossibly, be distinguished
from human hemolytic streptococci [4].
GCS identification can be difficult due to their close
kinship with group A streptococci—they have a common
evolutionary origin, and they are well-known for their
exchange of genetic material, share many of their virulence
genes, and cause similar diseases [5]. The study of the
epidemiology of human GCS infections has recently been
made possible mainly owing to the development of modern
methods of molecular diagnosis. GCS are mainly livestock
commensals or pathogens, although they can also be the
part of the human flora of the nose, throat, intestines, or
skin [3, 6]. The main origin of virulent species of GCS that
cause human diseases is animals, unpasteurized milk, and
unpasteurized dairy products [2, 6–10]. Infections caused
by streptococci can be invasive or noninvasive, and they
cannot be distinguished merely on the basis of their clinical
presentation [3].
Astete reports that Streptococcus equi is regarded as
the immediate antecedent of group C streptococci and is
also the cause of almost 2% of all infections caused by
GCS [1]. Table 1 depicts the species currently belonging to
GCS (Table 1). According to Facklam GCS contains four
species: S. dysgalactiae subs. dysgalactiae, S. dysgalactiae subs.
equisimilis, S. equi subs. equi, S. equi subs. zooepidemicus,
and S. constellatus subs. pharyngis [11]. The streptococcus of
group C, which most often causes infection in humans, is
Streptococcus dysgalactiae subs. equisimilis (SDSE) [10, 12];
it may cause skin infections (cellulitis) and recurrent blood
infections [13]. According to Clarke the GCS species, not
mentioned before, most often isolated from the human throat
is S. milleri [8], also known as S. anginosus group [11].
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Table 1: Phenotypic characteristics of group C streptococci.
Species Lancefield group 𝛽-hemolysis PYR test Sbla Treb Origin References
S. dysgalactiae
subs.
dysgalactiae
C − − v + Animals [11]
S. dysgalactiae
subs. equisimilis A, C, G + − − + Human, animals [2, 5, 7, 10–12, 14]
S. equi subs. equi C + − − − Animals [11]
S. equi subs.
zooepidemicus C + − + v Human, animals, unpasteurized dairy products [2, 11]
S. constellatus
subs. pharyngis C + − − + Human [11]
aSorbitol fermentation.
bTrehalose fermentation.
−, negative reaction; +, positive reaction; v, variable reaction.
2. Identification
In contemporary laboratories the identification according
to the carbohydrate group GCS strains may be conducted
by means of latex agglutination [5, 13]. Aside from the
classification according to the carbohydrate group, there are
many other identification methods, which will allow us to
discriminate species within GCS and to discriminate GCS
from other streptococci. Some selected phenotypic features
of the GCS species are shown in Table 1 (Table 1).
Phenotypes of group C streptococci and group G strepto-
cocci (GGS) form a large colony, which makes them different
from the phenotypes belonging to the S. anginosus group,
which form a small colony, irrespective of the carbohydrate
group [7]. The aforementioned S. anginosus group (called S.
milleri by some authors) contains three species: S. anginosus,
S. constellatus, and S. intermedius [7, 8, 11, 15]. The species
that belong to the S. anginosus group contain in their cellular
wall the carbohydrate groups A, C, F, and G or they contain
none [11]. GCS and S. anginosus group can be identified on
the basis of 𝛽-hemolytic activity [5]. All the species of the S.
anginosus group and almost all the phenotypes of GCS cause
beta-hemolysis except S. dysgalactiae subs. dysgalactiae [9, 11].
In order to discriminate GCS or GGS from GAS the PYR test
is applied (the L-pyroglutamyl amino-peptidase test) [5].The
PYR test shows a positive result only in the case of GAS; both
in the case of GCS and in the S. anginosus group no positive
reaction had been found [5, 11].
In Angeletti’s work we find two reliable optochin sen-
sitivity and bile solubility tests, the tests mentioned also in
Facklam’s observation [11, 16]. Facklam shows that virulent
streptococci, including those from group C, manifest a neg-
ative reaction in optochin sensitivity and bile solubility tests
[11]. Aside from the aforementioned methods, Clarke et al.
report that GCS can also be differentiated from other species
through their capacity for sorbitol and trehalose fermentation
([8], Table 1). Among the phenotypes belonging to GCS, only
S. equi subs. zooepidemicus can ferment sorbitol, whereas S.
dysgalactiae subs. dysgalactiae manifests variable reactions
[2, 11]. Almost all the phenotypes of GCS, except S. equi
subs. equi and S. equi subs. zooepidemicus, which manifests
a variable response, ferment trehalose [11]. It is interesting
to note that none out of the 49 strains attributed in 1933 by
Lancefield to group C fermented trehalose [4].
One can include within the molecular techniques of
streptococci identification the emm typing, MALDI-TOFMS
method (Matrix-Assisted Laser Desorption/Ionization Time-
of-FlightMass Spectrometry), and the sequencing of selected
genes. The examination of the presence of emm and emm-
like genes, called emm typing, allows us to determine the M
protein serotypes [17]. In Dinkla’s research the emm types
were identified by means of PCR analysis, with the use of
starters recommended by the Center of Disease Control [18].
In the case of GAS the emm gene sequence technique is
combined with T typing, a fact that is not possible in GCS
or GGS, for GCS/GGS contain no T proteins [17].
MALDI-TOF MS identification is based on the protein
composition of cell bacteria, especially ribosomal proteins.
In Angeletti’s tests 158 strains have been isolated, all of them
belonging to the viridans group streptococci (VGS), and
examined in the MALDI-TOF MS; then genes tuf, sodA, and
rpoB were amplified and sequenced [16]. It has been stated
that in Angeletti MALDI-TOF MS sensitivity obtained 100%
in comparison with the phenotypical tests [16]. To identify
S. dysgalactiae subs. equisimilis strains Ciszewski presents the
RISA method (analysis of ribosomal intergenic region) [19].
In the RISA method, in the course of PCR reaction, one uses
S. dysgalactiae species-specific primers and SDSE subspecies-
specific primers [19].
An alternative for the aforementionedmolecular identifi-
cation can be the sequencing of the 16S rRNA, in combination
with gyrB gene sequencing generally regarded as a golden
standard [16, 19, 20]. Zhou’s test confirms that by having
examined 181 isolates the similarities with the sequences in
GenBank reached over 99% and 96% [20]. According to Zhou
et al., however, the sequencing of the gyrB gene can be more
practical and more precise in identifying VGS strains than
other methods [20].
The basis of species identification appears to be the phe-
notypical tests used by many researchers; they confirm the
fact that they belong to a given species and that the findings
of MALDI-TOF MS are correct. Molecular techniques allow
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Table 2: Virulence factors and morbidity against human of group C streptococci.
Species Virulence factors Disease Origin References
S. equi subs. equi Protein Septic arthritis, meningitis Animals, human [1, 6, 11]
S. equi subs. zooepidemicus Surface-exposed protein (Szp) Meningitis, bacteremia,endocarditis
Unpasteurized milk;
animals [6, 9, 11]
S. equi subs. zooepidemicus
S. dysgalactiae subs.
equisimilis
Surface-exposed protein (Szp)
emm gene homologs,
streptokinase, streptolysin O
and S, M protein, hemolysin,
C5a peptidase, glyceraldehyde
3-phosphate dehydrogenase
(GAPDH), hyaluronidase
Pharyngitis, pneumonia,
endocarditis, meningitis, acute
glomerulonephritis, skin and soft
tissue infections, septic arthritis,
osteomyelitis, endometritis,
streptococcal toxic shock-like
syndrome, necrotizing fasciitis,
cellulitis, septic arthritis,
bacteremia, RFa, RHDb
Unpasteurized dairy
products, animals,
human
[2, 5, 7, 9–
11, 13]
aRF: rheumatic fever.
bRHD: rheumatic heart disease.
us also to detect or confirm the presence of some features
which cannot be examined by means of the phenotypical
methods of biochemical tests. These two groups of methods
are inseparably linked, and in order to precisely examine the
group C streptococci one should combine the phenotypical
methods with molecular techniques.
New methods of identification based on protein typing
or genome typing are barely available in Polish laboratories;
therefore latex tests prevail. Probably, such a situation is also
typical of other East andCentral European countries, or in the
developing countries. Therefore literature contains mainly
the findings from the highly developed countries.
3. Virulence Factors
The virulence factor in some species of GCS most frequently
mentioned is the M protein, the protein that also belongs
to group A streptococci [2, 5, 7, 10, 12, 14, 21, 22]. This
antiphagocytic, fibrillar, and surface-exposed M protein [14,
15] is encoded by the emm gene [12]. Bisno’s tests have
shown that M protein can mainly be found in S. dysgalactiae
subs. equisimilis isolates isolated from patients suffering from
acute pharyngitis [15]. There are over 80 well-known M
protein serotypes of groupA streptococci [15]. In comparative
research between M proteins of GAS and M proteins of
GCS isolates SDSE was examined from people and it was
found that the structures of M proteins of GAS were highly
homological to M proteins of GCS in the C repeat region but
the N terminus was unique [15].
It seems that M protein plays an important role in
rheumatic fever (RF) [5, 15]. McDonald and Bramhachari
have noticed that GCS isolates more often than GAS col-
onize the throats of Aboriginal population suffering from
RF incidence and rheumatic heart disease (RHD) [5, 21].
Dinkla’s work seems to confirm that M and M-like proteins
of group C streptococci take part in the pathogenesis of
rheumatic fever in some geographic regions [18]. All of
the 70 isolates S. dysgalactiae subs. equisimilis belonged to
GCS/GGS; 27 of them had the ability to bind collagen IV
and these were subjected to further analysis [18]. Out of 27
SDSE strains containing the emm gene, coding M proteins,
4 had the fog gene coding M-like fibrinogen binding protein
of GGS (FOG) [18]. These findings are confirmed in Haidan’s
and Rantala’s reports where GCS/GGS isolates were found,
and the isolates that have the fibronectin-binding protein
property can aggregate human platelets and can toxically
affect the endothelial cells [13, 23]. Dinkla’s research shows
that 27 SDSE strains owe their ability to bind collagen IV to
the hyaluronic acid capsule [18]. FurthermoreMcDonald and
Nataneli describe the capacities ofGCS for cross reactionwith
cardiac epitopes and their superantigenic features [21, 22].
Aside from M protein, some species of GCS (Table 2)
can produce a surface-exposed protein (Szp), streptokinase,
streptolysin O or streptolysin S [2, 10], and hemolysins [7].
Surface-exposed protein is produced by S. equi subs. zooepi-
demicus [11]. Chandnani indicates the SDSE strain to produce
streptokinase and streptolysin O and shows theories about
the pathogenesis of rheumatic fever [2]. There is a direct
cytotoxic influence of streptolysin O on the cardiac cells and
other organs or there are antigenic determinants between the
components of an organism and some specific tissues, such
as the brain or heart, that is a result of immunologic cross
reactivity [2]. Following a comparative analysis of the GAS
genome with the SDSE genome, Silva andWatanabe confirm
that they contain related virulence factors [10, 14].
Besides the aforementioned virulence factors SDSE iso-
lates have C5a peptidase, glyceraldehyde 3-phosphate dehy-
drogenase, and hyaluronidase [10]. There are also several
important GAS virulence factors, which are not found in
the SDSE genome, for example, cysteine protease, and a
superantigen homolog [14]. SDSE enzymes, matrix metal-
loproteinases, and plasminogen binding GAPDH enzyme
contribute to dissemination in the body and proliferation. An
analysis of the genome of SDSE 167 strain has shown that it
excretes lyases decomposing carbohydrates of the host, while
at the same time this genome metabolizes carbohydrates
in the Entner-Doudoroff pathway; this region contains the
enzymemetabolizing polysaccharides, whichmay contribute
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to a higher virulence of SDSE 167 strain [14]. Watanabe et al.
claim that SDSE 167 strain is the most virulent human strain
[14].
4. Pathogenicity
Among the diseases caused by the species of GCS the dom-
inating ones are pharyngitis, meningitis, and endocarditis
(Table 2). According to Danish data (1999–2002), GCS infec-
tions take the last place among streptococcal infections, but
they constitute as many as 6% of all streptococcal infections
[3]. This has also been confirmed by the Norwegian obser-
vations of 1999–2013, where out of 512 invasive infections
GCS was the cause of 24 cases (4,7%) [12]. In both reports,
the risk of infection increases with the patient’s age [3, 12].
Among other factors that predispose one to infections are
diabetes, tumors, cardiac conditions, and alcohol abuse [3],
whereas Rantala adds immunosuppressive therapy, multiple
morbidities, and skin lesions as potential predisposing factors
[13].
The most frequent clinical form of invasive virulent
species of GCS infections are infections of bones, joints,
and blood infections, and the noninvasive infections of the
upper respiratory tracts [12]. The mortality rate during the
first 30 days of the disease, in the Danish research, equaled
21%, whereas in the Norwegian research it equaled 9%,
and it increased with age and with respect to the kind of
disease [3, 12]. Ekelund et al. reports that the highest rate
concerned patients with GAS (23%) and GCS infections
(21%) [3]; in Oppegaard et al. the mortality rate in GAS
infections was 13% [12]. Both Ekelund et al. and Oppe-
gaard et al. list similar diseases: skin infections (erysipelas,
cellulitis), necrotizing fasciitis, and toxic shock syndrome
[3, 12].
Rantala presents two cases of elderly patients with recur-
ring bacteremia caused by the most frequent GCS isolates,
SDSE, and a broad range of diseases caused by the following
subspecies: pharyngitis, tonsillitis, skin infection, soft tissue
infection, wound infections, erysipelas, cellulitis, necrotizing
fasciitis, streptococcal toxic shock-like syndrome, pneumo-
nia, septic arthritis, osteomyelitis, meningitis, endocarditis,
and bacteremia [13].
The findings of the British Health Protection Agency and
Watanabe are alarming. They have shown a 100% increase
of bacteremia between 2006 and 2012 and an increase of
SDSE infections in Asia, Europe, and the USA [12, 14]. Of
particular interest are the reports about the relations between
GCS with the pathogenesis of rheumatic fever in Australia
and India [5, 21, 23] and first documented zoonotic diseases
[6, 8, 9, 22, 24].
As has already been mentioned, though RF pathogenesis
is not clear only in the upper respiratory tract infection, GAS
may directly lead to rheumatic fever. Haidan’s studies have
shown that in Australia higher indicators of isolation of GCS
have been found as well as the highest rate of RF-dependent
morbidity in the world [23], a fact which, as researchers
say, may be related to high RF and RHD morbidity among
Aboriginal communities of Australia [5, 21].
Nataneli et al. have described an American case of
poststreptococcal syndrome uveitis (PSU), which is the first
documented case of complications following pharyngitis and
caused by GCS infection [22]. The patient was a 24-year-
old man with HLA-B27 positive genotype (this genotype
predisposing an individual also to poststreptococcal reactive
arthritis). Morsch, however, describes the case of a 72-year-
oldman, suffering from tophaceous gout, in whomolecranon
bursitis developed as the result of a GCS infection [24]. The
author notes that until now circa 15 cases of septic arthritis
(GCS) have been documented, but none have been related to
bursitis [24].
In publications one can find some data concerning
zoonotic diseases. The first report describes the case of a 13-
year-old boy who lived on a horse farm; he became ill with
meningitis caused by S. equi subs. equi [6]. The second case
is of a 13-year-old girl suffering from meningitis caused by
S. equi subs. zooepidemicus [9]. A day before her illness she
took part in horse races [9]. A description of GCS-dependent
meningitis with cavernous sinus in an 18-year-old man is
worthmentioning [8]. Virulent species ofGCS can also cause,
among other things, impetigo, epiglottitis, and polyarthritis
[5, 6, 21].
5. Conclusions
(1) Virulent species of group C streptococci, which cause
infection in people, aremost often animals’ pathogens
and belong to bacteria that are difficult to be identi-
fied. Due to the common origin of GCS and GAS the
method of identification is to combine phenotypical
and molecular techniques.
(2) The study of the epidemiology of human GCS infec-
tions is possible owing to the application of modern
NGS (Next Generation Sequencing) methods in rou-
tine investigations.
(3) Some species of GCS, chiefly SDSE, have many
virulence factors found in GAS like M protein, strep-
tokinase, and streptolysins, but there are some that are
missing like cysteine protease. There are assumptions
that virulent species of GCS can be related to the
pathogenesis of rheumatic fever and rheumatic heart
disease, especially among Aboriginal population of
Australia.
(4) Themain origins of virulent species ofGCS are unpas-
teurized dairy products, animals, and humans.
(5) The most frequent diseases are pharyngitis and
meningitis. The most frequent GCS isolates from
human infection is SDSE.
(6) The predisposing factors are, among other things, age
and chronic diseases. The range of GCS-dependent
diseases is broad, including infections related to the
respiratory system, skin infections and soft tissue
infections, necrotizing fasciitis, streptococcal toxic
shock syndrome, septic arthritis, osteomyelitis, endo-
carditis, and bacteremia.
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